University Hospitals of Cleveland

University Hospitals of Cleveland is a leading non-profit medical facility in Cleveland, Ohio, United States. With 150 branches across the state of Ohio, it comprises of a set of hospitals, outpatient facilities and primary care physicians. At the center of the network is University Hospitals’ Case Medical Center. The major associate of Case Western Reserve University School of Medicine, University Hospitals Case Medical Center is the place for some of the finest clinical and research facilities in the world, including transgenic research.

The main campus of the University Hospitals of Cleveland comprises the globally acclaimed Rainbow Babies & Children’s Hospital, MacDonald Women’s Hospital, and Ireland Cancer Center. University Hospitals of Cleveland is also a main facility for biomedical research, rating among the best 15 facilities in the US with about $75 million in yearly extramural research financing and an additional $10 million in many different clinical trials, and is the major associate among many teaching hospitals affiliated with the Case Western Reserve University School of Medicine.

Vision 2010 is the biggest construction and advancement project in the history of University of Hospitals. Novel construction will comprise of new 200-bed cancer hospital, a new neonatal intensive care unit, enhanced emergency room centers at CMC, and new building at other hospital locations.

In 1995 University Hospitals of Cleveland was a 947-bed academic medical facility with more than 1,200 faculty, and 6,000 patient and support staff, teaching and preparing 100s of doctors and medical specialists. As the major associate of Case Western Reserve University School of Medicine, University Hospitals of Cleveland and its academic counterpart form Ohio’s biggest biomedical research facility.

Major Research Centers

The Case Transgenic and Targeting Facility is the major service producing genetically altered mice for the Cleveland Biomedical community. The transgenic center provides assistance to researchers associated with Case Western Reserve University, University Hospitals of Cleveland, the VA Hospital, Taussig Cancer Center, Case Comprehensive Cancer Center, Metro-Health Hospital, and the Cleveland Clinic Lerner Research Institute. Services include producing transgenic and gene targeted mice, conducting rederivations, ICSI, cryopreservation, in vitro fertilization and tailored support. A large lab suite accommodates the transgenic center and is set with 2 tissue culture hoods, 4 microinjection stations, and 3 surgery hoods.

The transgenic facility functions on a fee for service foundation, and offers consultation with all services. The Case Transgenic & Targeting Facility website has novel material constructed to notify and teach researchers while they make orders over the Internet. A transgenic center member calls the investigator for one-on-one consultation and the investigator gets a link on which they can follow up on job progress. Recent rates of accomplishment, fees and approximates of job handling times can be viewed on the site.

In the previous 10 years, there have been many different endeavors to move healthy genes into the cells of the air pathways of cystic fibrosis patients. Most of the trials that have been conducted are engaged with the utilization of a viral vector, connecting the healthy gene to a virus that will penetrate cells. Unfortunately, the results have been less than positive. University Hospitals of Cleveland involves a comprehensive and well informed patient population for clinical trials that go along with the latest treatments.